Meanwhile, there's been some talk over the possibility of John Gibson getting moved by the trade deadline. The 31-year-old Anaheim Ducks goaltender has been a fixture in the rumor mill for the ...

Do the Edmonton Oilers really need another goalie? What do the Boston Bruins need? Could the Sharks, Kings and Kraken trade anybody? All that and more. 0:00: After Sidney Crosby had the QMJHL ...

Gibson appeared at MegaCon in Orlando, Florida, on the heels of his movie 'Flight Risk' Gerardo Mora/Getty After nearly 50 years in the entertainment industry, Mel Gibson still has a dream ...

Biogen is continuing to thin its pipeline, dropping a phase 2 program acquired in the $7.3 billion Reata Pharmaceuticals buyout and kicking early-stage Alzheimer’s and Parkinson’s prospects ...

Biogen expects full-year 2025 total revenue to decline by a mid-single digit percentage. The company’s stock was down about 6% at 10 a.m. on Wednesday with shares priced at around $131 apiece.

Biogen posted fourth-quarter revenue and profit that topped expectations as its cost cuts showed progress and new products, including its breakthrough Alzheimer's treatment Leqembi, saw growth.

Biogen's Q4 2024 earnings showed slight revenue growth but Wall Street remains unimpressed due to weak guidance and declining key drug franchises. Leqembi's commercial performance is disappointing ...

Biogen (NASDAQ:BIIB) shares traded flat in the premarket on Wednesday after the Alzheimer’s drug developer reported better-than-expected Q4 2024 financials while its full-year outlook ...

American biotechnology company Biogen (BIIB) expects lower profits in 2025, impacted by a stronger dollar (DX=F, DX-Y.NYB) and competition for its multiple sclerosis (MS) drugs. Despite this ...

Overall, Biogen’s fourth-quarter revenues clocked in at $2.46 billion, coming in above Wall Street’s estimate of $2.41 million. Full-year revenues declined 2% over 2023 to $9.7 billion, which ...

John Henry Gibson, a beloved member of his family and community, Columbus, Texas, passed away at the age of 78 on January 30, 2025, after a long battle with cancer. He was born on October 4, 1946, to ...

(Reuters) -Biogen forecast 2025 profit below last year's levels and Wall Street expectations on Wednesday, hurt by a strong dollar and fierce competition for its drugs to treat multiple sclerosis.